Today's Edition News Sports Obits Digital FAQ Events Contests Classifieds Autos Jobs Newsletters Search
ADVERTISEMENT
ADVERTISEMENT

Missouri is resuming use of the Johnson & Johnson COVID-19 vaccine after federal scientific advisers decided its benefits outweigh a rare risk of blood clots.

The state made the announcement Friday night in a tweet in response to U.S. health officials lifting an 11-day pause on the single-dose vaccine.

The state said that providers with J&J vaccine in stock can immediately begin administering it, and shipments from the federal government will resume next week. Just more than 105,000 doses of J&J had been administered in Missouri before the pause.

The federal government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.

But ultimately, federal health officials decided J&J's one-and-done vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.

COMMENTS - It looks like you're using Internet Explorer, which isn't compatible with our commenting system. You can join the discussion by using another browser, like Firefox or Google Chrome.
It looks like you're using Microsoft Edge. Our commenting system is more compatible with Firefox and Google Chrome.
ADVERTISEMENT
ADVERTISEMENT